Sahmyook Medical Center is a large private hospital located in Seoul, South Korea. It admits more than 30,000 patients per year. Sahmyook Medical Center also houses the Sahmyook Children's Hospital, Proton Treatment Center, Transplantation Institute & Liver Center.

During the past decade, Sahmyook Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sahmyook Medical Center" are "COVID-19" (2 trials). Many other conditions were trialed in "Sahmyook Medical Center" in a lesser frequency.

Most popular intervention types in "Sahmyook Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Pyramax" (1 trials) and "Pyronaridine-Artesunate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sahmyook Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sahmyook Medical Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sahmyook Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sahmyook Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".